A mathematical model to study the effects of drugs administration on tumor growth dynamics.

A mathematical model for describing the cancer growth dynamics in response to anticancer agents administration in xenograft models is discussed. The model consists of a system of ordinary differential equations involving five parameters (three for describing the untreated growth and two for describing the drug action). Tumor growth in untreated animals is modelled by an exponential growth followed by a linear growth. In treated animals, tumor growth rate is decreased by an additional factor proportional to both drug concentration and proliferating cells. The mathematical analysis conducted in this paper highlights several interesting properties of this tumor growth model. It suggests also effective strategies to design in vivo experiments in animals with potential saving of time and resources. For example, the drug concentration threshold for the tumor eradication, the delay between drug administration and tumor regression, and a time index that measures the efficacy of a treatment are derived and discussed. The model has already been employed in several drug discovery projects. Its application on a data set coming from one of these projects is discussed in this paper.

[1]  Z. Bajzer,et al.  Conceptual frameworks for mathematical modeling of tumor growth dynamics , 1996 .

[2]  C. Harley,et al.  Cancer treatment by telomerase inhibitors: predictions by a kinetic model. , 2003, Mathematical biosciences.

[3]  R. Wasserman,et al.  A patient-specific in vivo tumor model. , 1996, Mathematical biosciences.

[4]  Gene F. Franklin,et al.  Feedback Control of Dynamic Systems , 1986 .

[5]  E K Rowinsky,et al.  Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model. , 2000, European journal of cancer.

[6]  X. Zheng,et al.  A cellular automaton model of cancerous growth. , 1993, Journal of theoretical biology.

[7]  Miljenko Marušić,et al.  Generalized two-parameter equation of growth , 1993 .

[8]  Janet Dyson,et al.  Asynchronous exponential growth in an age structured population of proliferating and quiescent cells. , 2002, Mathematical biosciences.

[9]  John A. Adam,et al.  A mathematical model of cycle-specific chemotherapy , 1995 .

[10]  Paolo Magni,et al.  Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents , 2004, Cancer Research.

[11]  M. Chaplain Avascular growth, angiogenesis and vascular growth in solid tumours: The mathematical modelling of the stages of tumour development , 1996 .

[12]  M. Selvakumaran,et al.  Use of a surrogate marker (human secreted alkaline phosphatase) to monitor in vivo tumor growth and anticancer drug efficacy in ovarian cancer xenografts. , 2000, Gynecologic oncology.

[13]  H M Byrne,et al.  A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy. , 2000, Mathematical biosciences.

[14]  P Forouhi,et al.  Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response , 2000, British Journal of Cancer.

[15]  Zeljko Bajzer,et al.  Combining Gompertzian growth and cell population dynamics. , 2003, Mathematical biosciences.

[16]  M. Skinner,et al.  An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics , 2002, Cancer Chemotherapy and Pharmacology.

[17]  L. Norton A Gompertzian model of human breast cancer growth. , 1988, Cancer research.

[18]  Dietmar P. F. Möller,et al.  Biomedical Modeling and Simulation on a PC , 1993, Advances in Simulation.

[19]  Z. Agur,et al.  A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs. , 1992, Mathematical biosciences.